ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SDI Sdi Group Plc

55.50
-0.10 (-0.18%)
Last Updated: 08:00:09
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sdi Group Plc LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -0.18% 55.50 55.00 56.00 55.50 55.50 55.50 55,562 08:00:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 67.58M 3.87M 0.0372 14.92 57.75M
Sdi Group Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker SDI. The last closing price for Sdi was 55.60p. Over the last year, Sdi shares have traded in a share price range of 55.00p to 179.50p.

Sdi currently has 104,050,044 shares in issue. The market capitalisation of Sdi is £57.75 million. Sdi has a price to earnings ratio (PE ratio) of 14.92.

Sdi Share Discussion Threads

Showing 1551 to 1572 of 4050 messages
Chat Pages: Latest  66  65  64  63  62  61  60  59  58  57  56  55  Older
DateSubjectAuthorDiscuss
17/2/2019
00:28
.................. The Prion Story ...............

This has come as no surprise to me. There is now a lot of new research going on around amyloid angiopathy ... soon IMO many old diseases will be renamed as Prion Diseases.



A new prion disease?

Cerebral amyloid angiopathy, a rare brain illness, may be caused by prions
Like CJD, in other words, but with a protein also involved in Alzheimer’s


Feb 16th 2019

A paper published in this month’s Annals of Neurology, by Gargi Banerjee and David Werring of University College, London, adds to evidence that prion diseases are more widespread and varied than had been realized.

Such diseases are caused by miss-folded protein molecules that have the unfortunate property of triggering similar miss-folding in others of their kind, and so transmitting their pathological character to previously healthy molecules.

They came to public attention in the 1990s, when a variant form of the best known of them, Creutzfeldt-Jakob disease (cjd), was shown to be transmissible from cattle to people. This sparked fears of an epidemic among beef eaters, which fortunately failed to come to pass. Ever since, doctors have kept an eye open for anything similar. Dr Banerjee’s and Dr Werring’s results suggest cerebral amyloid angiopathy (caa), a haemorrhage-causing illness closely related to Alzheimer’s, may be an example.

buywell3
14/2/2019
09:01
owwnski - Agreed - At least multiple revenue streams unlike some coys you follow!!!
pugugly
14/2/2019
08:52
Picked up some of these yesterday, I like the business model.
owenski
13/2/2019
16:20
Some nice director buys today.

Very reassuring.

xajorkith
13/2/2019
13:57
Interesting news release dated yesterday re Graticules from the vendors - great to see involvement in Nano/Biophotonics and a number of other new fields:



"GRATICULES AT SPIE BIOS & PHOTONICS WEST 2019
February 12, 2019

Pyser Optics Graticules Division had very successful shows in San Francisco at both SPIE BiOS and SPIE Photonics West 2019. We would like to thank you all for visiting our booth.

The BiOS Conference and Expo opened on the 2nd of February 2019, with over 2,500 papers and presentations BiOS is the largest biophotonics, biomedical optics, and imaging conference. Pyser Optics was displaying its wide range of micropattern products: standard and custom made reticle targets, precision apertures, gratings and calibration slides in glass, and electroformed metal foil.

Different key topics were discussed during the two days of conference such as Photonic Therapeutics and Diagnostics, Nano/Biophotonics, Biomedical Spectroscopy, Microscopy, and Imaging, etc.

As soon as BiOS conference concluded, we were setting up for the Photonics West Exhibition, which started on the 5th of February 2019. It is the world’s largest photonics technologies event, which featured over 1,300 companies this year.

We were very delighted to meet a large number of new companies as well as existing partners and customers at the show. We received numerous challenging and interesting enquiries for different industries and applications such as custom apertures, custom USAF test charts, multi-aperture foil discs and many calibration/alignment reticles.

We look forward to work on those projects and bringing to our customers the innovative solution to their most complex requirements."

rivaldo
13/2/2019
10:31
ref Primarybid. I think they themselves went through a learning curve with the Placing. SDI is not like the other mainly natural resource stocks or extremely speculative stocks such as VRS that have been placed before.

I would suspect primarybid had to get the dictionary out to look up what ''pre tax profit'' and ''positive earnings per share'' actually meant!

pj 1
13/2/2019
10:04
Well I too am annoyed that I wasn't quick enough to buy at 34. But I then rectified my mistake by buying around 36.5 :0).

Again, for the inorganic and organic growth drivers, and the excellent cash flows, I don't see why this should trade below 14x forward earnings = 43p

pireric
13/2/2019
09:54
It's a difficult call for management and they did what they thought was best. To be fair, I saw the announcement pretty quickly but wasn't able to acquire any! Am I bothered, no, as there has been ample opportunity to buy at the same level recently and in quantity. The most important thing for me is where the share price will be in a couple of years time, which should be a good deal higher than where we are now.
hastings
13/2/2019
09:48
That's fair enough but we did have ample opportunity to pick them up at under 33p over the past few weeks. Glad to see the share price now rising.
fozzie
13/2/2019
09:05
Apparently existing Institutions such as Herald took part in the placing along with newbies including Canaccord. I would agree with rivaldo that any overhang should have cleared.
hastings
13/2/2019
08:56
Good to see buying now coming in at the full 37p offer. Perhaps all this activity has now cleared the overhang which has held the share price back recently.
rivaldo
13/2/2019
08:34
Possibly but at that level would be on 11x forward earnings, approaching 9% free cash flow yield.

Already over 8.5% at current levels. Super confident in the medium term story here. They just keep executing. Only reason this is down is because of the placing, which is almost irrelevant because the deal was 5% accretive to fy20 eps

Ie all things equal, this is 5% cheaper than it was yesterday!

pireric
13/2/2019
08:08
Not always, but often I see a return to placing price, before the share price gets going.
bamboo2
13/2/2019
08:03
I've increased my position by over 50% on the bell. Just think it's too cheap at current levels

I think this ought to trade at 14x PE at a minimum given the strong cash flows, which is now 43p

pireric
13/2/2019
07:05
Broker now forecasts revenue next year of £20.3m with a pre-tax profit of £3.7m and a healthy net cash position of £2.2m. Given that SDI also added yesterday that it continues to trade comfortably in line with its expectations, then there is obviously scope for an outperform along the way. Forward PER of 11 for a growth stock with an increasingly diverse yet complementary mix looks excellent value to me.
hastings
13/2/2019
04:35
Turnover for the current year should come in at around 16.75M

I have now penciled in 20M turnover for the following year and 4M profit

Full year contributions from Fistreem, Thermal Exchange and Graticules
plus X selling to existing clients plus new ODM opportunities.

SDI are on a roll I would not put it past them to acquire another company around August this year ... it's all about timing and the price.

And thus far they seem to be doing both well.

I am all for this acquisition splurge ... 4 companies ( including the Dark Matter buy) in around 4 months or something like that.

If a predator does step in soon then at least they will have to cough up a decent wedge to get the nod.

buywell3
12/2/2019
22:58
Excellent news - just a shame I missed the PrimaryBid deadline!

Some juicy extracts too from today's RNS:

- "The Company continues to trade comfortably in line with its expectations" - I like the sound of "comfortably"
- the placing was "significantly oversubscribed"
- and brought in "new institutional investors". As if the share register wasn't top-notch enough already for a £33m tiddler
- Graticules brings in strong recurring revenues, as well as being earnings enhancing

Finncap now forecast 3.1p EPS for the year starting 1st May. It's not hard to see the share price approaching that 51p target level in the near/medium-term.

rivaldo
12/2/2019
20:30
Only just noticed this, but seems a very good fit at just over 5x their March 2018 operating profit of 0.65m.

Modest dilution to stengthen the balance sheet, but appropriate given that "the pipeline of potential acquisitions also remains strong".

xajorkith
12/2/2019
17:56
And not before time

Kevin Cook, Managing Director of Pyser Optics said, “We are delighted to announce the sale of the Graticules business today to Scientific Digital Imaging PLC. We and SDI believe that this is the right decision for Graticules and will allow the business to flourish and grow its turnover and profitability even further. It’s a very exciting time for Graticules. Whilst the business will have new owners, we hope that the close working ties will continue not only through the transition period but beyond as we continue to work together in the normal course of business.”

Neil Blackford, Managing Director of Graticules Optics Limited said “We would like to thank Pyser Optics for their support over the years. Becoming an independent company under the SDI umbrella will allow us to grow our turnover and profitability even further, with a focus on the scientific market.”

buywell3
12/2/2019
17:33
Very happy indeedy :0). Looks a really interesting product set, pretty much paying 6.5x p/en immediately earnings enhancing even with the are element.

Finncap bump their target price to 51p from 48p.

pireric
12/2/2019
17:20
Another cracking looking acquisition and oversubscribed placing.Retail offer with Primary Bid not surprisingly closed very quickly.
hastings
11/2/2019
17:33
ATIK Cameras

I see that they have completed recruiting and are now doing Beta trails on new 'Dusk' capture software ... which should be released very soon

Posted December 12, 2018

Recently got my link to Atik’s new capture software Dusk to start beta testing.
It has a completely new look but lots of familiar functions and a few new things.
Only had a quick try with it last night so hopefully the weather will clear long enough for me to get a good go with it under real conditions rather than in front of the tv !!!

This company based in Portugal are doing very well for the group , long may it continue



Whilst the above link displays an impressive world coverage for such a small company

I would like to see a Distributor appointed to cover South America , possibly firstly Brazil

Likewise another in India , Delhi or Mumbai perhaps

And one in New Zealand , clear skies down there , Auckland or Wellington

Obviously not all at once ... but one continent or country a year would be good.

I also note that ATIK are going to attend quite a lot of shows this year



Keep up the good work Amy

buywell3
Chat Pages: Latest  66  65  64  63  62  61  60  59  58  57  56  55  Older

Your Recent History

Delayed Upgrade Clock